Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRos Agro S Regulatory News (AGRO)

  • This share is currently suspended. It was suspended at a price of 0.314

Share Price Information for Ros Agro S (AGRO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.314
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.314
AGRO Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

5 Apr 2022 08:32

RNS Number : 3021H
Ros Agro PLC
05 April 2022
 

http://www.rns-pdf.londonstockexchange.com/rns/3021H_1-2022-4-5.pdf

 

ROS AGRO PLC

(the "Company")

 

MINUTES OF THE ANNUAL GENERAL MEETING OF THE SHAREHOLDERS HELD IN ACCORDANCE WITH THE COMPANY'S ARTICLES OF ASSOCIATION AT THE COMPANY'S REGISTERED OFFICE ON 1ST APRIL 2022 AT 10:00 A.M.

 

 

Present:

 

Fiduciana Nominees (Cyprus) Limited - represented by Ms. Ganna Khomenko - Shareholder

Fiduciana Trustees (Cyprus) Limited - represented by Ms. Ganna Khomenko - Shareholder

Fiduciana Directors Limited - represented by Ms. Ganna Khomenko - Shareholder

Fiduciana Management Limited - represented by Ms. Ganna Khomenko - Shareholder

 

RIGPA LIMITED - represented by Ms. Maro Evi Koulla Griva by proxy - Shareholder

 

BNY (Nominees) Limited - represented by Ms. Maro Evi Koulla Griva by proxy - Shareholder

 

Mr. Yury Zhuravlev - represented by Ms. Ganna Khomenko - Shareholder

 

 

Absent:

 

Granada Capital CY Limited - represented by Ms. Tatiana Gurina - Shareholder

 

 

1. Chairperson

 

IT WAS RESOLVED that Ms. Maro Evi Koulla Griva, representing the majority of shareholders, be appointed as Chairperson of the Meeting. IT WAS NOTED that a quorum was present and that the Meeting was duly constituted in accordance with the Company's Articles of Association.

 

The chairman stated that the purpose for convening this Annual General Meeting is to approve or reject the following items as circulated on the Notice dated 10th March 2022:

 

1. Adoption of the annual Standalone Financial Statements for 2021; 

 

2. Adoption of IFRS Financial Statements for 2021;

 

3. Adoption of the Directors' Report for 2021;

 

4. Adoption of the Auditor's Report for 2021;

 

5. Adoption of the Annual Report for 2021 (LSE);

 

6. Adoption of the Auditor for audit of Standalone and IFRS Financial Statements on 2022;

 

7. Adoption of the remuneration for the Auditor of Standalone and IFRS Financial Statements on 2022;

 

8. Payment of Dividends;

 

9. Remuneration of Directors;

 

10. Election of the Board of Directors;

 

11. Powers of Directors;

 

12. Any other matters proposed by the Directors;

 

 

 

 

 

 

After due consideration, the shareholders voted what is in the best interest of the Company and have by a majority of votes, resolved as follows:

 

2. Resolutions

 

IT WAS RESOLVED by all shareholders, except Granada Capital Cyprus Limited, AS FOLLOWS:

 

1. That the Annual Standalone Financial Statements for 2021 are approved and adopted.

 

2. That the IFRS Financial Statements for 2021 are approved and adopted.

 

3. That the Directors' Report for 2021 is approved and adopted.

 

4. That the Auditor's Report for 2021 is approved and adopted.

 

5. That the Annual Report for 2021 (LSE) is approved and adopted.

 

6. That the current Auditor is maintained for the financial year 2022.

 

7. That the remuneration of the Auditor is to be decided upon by the Board of Directors.

 

8. Payment of Dividends - not to distribute profit to shareholders as dividends for 2021 (apart from the part already paid as interim dividends for the year ending as of 31.12.2021 in the amount of USD 119,732,903.28).

 

9. That the remuneration of the Directors is to be decided upon and approved by the Board of Directors.

 

10. That the Board of Directors is elected in the following composition, for the next financial year, effective as from the closing of this Meeting:

Mrs. Ganna Khomenko;

Mr. Maxim Basov;

Mrs. Tatiana Gurina;

Mr. Konstantinos Konstantinidis; and

Mrs. Andri Koumourou.

11. Powers of Directors - to grant the Directors the powers to decide on the amount of shares of JSC Rusagro Group for public offering as result of its transformation into a public company;

 

 

3. Termination

 

There being no other business to transact the Chairperson declared the Meeting closed.

 

 

Signed:

 

 

……………………………….. ...............................................

Maro Evi Koulla Griva Ganna Khomenko

Chairperson For and on behalf of:

For and on behalf of: Fiduciana Nominees (Cyprus) Limited

BNY (Nominees) Limited by Proxy Fiduciana Management Limited

RIGPA LIMITED by Proxy Fiduciana Trustees (Cyprus) Limited

Fiduciana Directors Limited

Mr. Yury Zhuravlev by Proxy

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDELBBLZLLBBQ
Date   Source Headline
10th Mar 20207:20 amRNSDividend Declaration
10th Mar 20207:00 amRNSAnnual Financial Report
6th Mar 20208:56 amRNSTransaction in Own Shares
4th Mar 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Jan 202012:02 pmRNSPrice Monitoring Extension
18th Nov 20199:54 amRNS3rd Quarter Results - Replacement
18th Nov 20197:00 amRNS3rd Quarter Results
24th Sep 20194:35 pmRNSPrice Monitoring Extension
13th Sep 201911:30 amRNSEGM Statement
2nd Sep 20198:04 amRNSStatement re results of internal investigation
22nd Aug 201912:07 pmRNSNotice of EGM
19th Aug 20191:47 pmRNSDividend Declaration
19th Aug 20198:01 amRNSHalf-year Report
19th Aug 20198:00 amRNSDividend Declaration
13th Jun 20198:06 amRNSChange of Registered Office
20th May 20191:38 pmRNS1st Quarter Results
20th May 20198:00 amRNS1st Quarter Results
29th Apr 20197:53 amRNSAGM Statement
26th Mar 20194:40 pmRNSSecond Price Monitoring Extn
26th Mar 20194:35 pmRNSPrice Monitoring Extension
21st Mar 20196:01 pmRNSStatement re internal investigation
20th Mar 20194:56 pmRNSNotice of AGM
19th Mar 20197:00 amRNSGM Statement
15th Mar 201912:52 pmRNSDividend Declaration
14th Mar 20191:25 pmRNSAnnual Financial Report
14th Mar 201912:59 pmRNSAnnual Financial Report
14th Mar 20197:00 amRNSAnnual Financial Report
8th Mar 20194:35 pmRNSPrice Monitoring Extension
22nd Feb 20194:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
20th Feb 20197:10 amRNSNotice of GM
13th Nov 20187:00 amRNS3rd Quarter Results
12th Nov 20187:00 amRNS3rd Quarter Results
15th Oct 20187:23 amRNSDirector/PDMR Shareholding
3rd Oct 20188:23 amRNSDirector/PDMR Shareholding
19th Sep 20182:26 pmRNSDirector/PDMR Shareholding
17th Sep 20187:45 amRNSGM Statement
13th Aug 20189:49 amRNSNotice of GM
13th Aug 20189:39 amRNSNotice of GM
13th Aug 20189:16 amRNSDividend Declaration
13th Aug 20189:15 amRNSHalf-year Report
30th May 20189:26 amRNSDirector/PDMR Shareholding
14th May 20188:42 amRNS1st Quarter Results
18th Apr 20187:53 amRNSAGM Statement
11th Apr 20187:26 amRNSDirector/PDMR Shareholding
20th Mar 20182:43 pmRNSNotice of AGM
19th Mar 20189:04 amRNSAnnual Financial Report
19th Mar 20188:53 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.